Leadership

Vivek K. Jayaraman
President, Chief Executive Officer, Director

Mr. Jayaraman was appointed as Cerus’ chief executive officer on July 1, 2026.  He previously served as chief operating officer (2020-2026), with oversight of commercial operations and supply chain, and as chief commercial officer (2016-2020). Prior to Cerus, Mr. Jayaraman led TriVascular’s commercial expansion as the company grew from a preclinical, venture-backed startup into a publicly traded, global medical device company. Prior to TriVascular, Mr. Jayaraman served in numerous executive roles at Medtronic in both the U.S. and Asia. Mr. Jayaraman received his M.B.A. from the Wharton School at the University of Pennsylvania and holds dual bachelor’s degrees from the University of Michigan.

Richard J. Benjamin, MBChB, Ph.D., FRCPath
Chief Medical Officer

Dr. Benjamin was appointed as our Chief Medical Officer (CMO) in July 2015. Previously, he served as CMO for the American Red Cross where he oversaw donor and patient safety issues for 40% of the US blood supply. Prior to Red Cross, he served as Medical Director at the Adult Transfusion Service at the Joint Program in Transfusion Medicine at Harvard University. Dr. Benjamin served as a Board Member and Regional Director for North America for the International Society of Blood Transfusion (ISBT) and is an active member of the Association for the Advancement of Blood & Biotherapies (AABB). He has also served on the DHHS Secretary’s Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) in the U.S. Dr. Benjamin is an Adjunct Professor of Pathology at Georgetown University and author of 130 peer-reviewed publications. He received his M.D. from the University of Cape Town and his Ph.D. from Cambridge University, England in Immunology, and he completed post-doctoral research at Stanford University, CA.

Erik Bosman
Vice President, Global Supply Chain

Mr. Bosman was appointed Vice President, Global Supply Chain in 2021.  He joined Cerus in 2013 as Director, Finance and Operations EMEA. Prior to joining Cerus, he held leadership roles at Jabil, International Paper, Moore Stephens, and PricewaterhouseCoopers, where he developed expertise across finance, manufacturing, and global operations. Mr. Bosman holds degrees in accounting, auditing, and business administration, and is a Certified Supply Chain Professional (CSCP) through APICS. He combines deep financial expertise with strategic supply chain leadership to help organizations improve resilience, efficiency, and sustainable growth in highly regulated global industries.

Christian Boutemy
Vice President & Managing Director, Cerus International

Mr. Boutemy was appointed Vice President, International Commercial Operations in 2025. In 2017, he joined Cerus as Sr. Director, Sales EMEA.  In this role, he leads Cerus’ international commercial operations across Europe, Canada, Middle East, and Africa. Before joining Cerus, Mr. Boutemy held a series of executive leadership roles at Macopharma, including Managing Director of the Biotherapy Division and Managing Director for North America and the UK. Throughout his tenure, he successfully doubled sales in multiple business units, launched new organizations, recruited and developed high-performing teams, and held full strategic and P&L responsibility for multimillion-euro operations. He earned a Master of Science in Management and a Bachelor of Business Administration from IESEG School of Management in Lille, France, and has completed executive leadership training at INSEAD, McGill University, and Moortgat Leadership Institute.

Kevin D. Green
Vice President Finance and Chief Financial Officer

Mr. Green was appointed our Chief Financial Officer in 2013. From 2006 to 2013, Mr. Green served in several roles for us including Senior Director of Finance, Controller, and later, Vice President, Finance and Chief Accounting Officer. From 2000 until 2006, Mr. Green held various financial management positions with Macromedia, Inc. (acquired by Adobe Systems in 2005), including Director of Finance and Assistant Controller. Prior to joining Macromedia, Mr. Green was a member of PricewaterhouseCoopers LLP in the Assurance and Business Advisory Services division.

Mr. Green is a certified public accountant (inactive).

Bronk Harms
Vice President, US Commercial Operations

Mr. Harms was appointed Vice President, US Commercial Operations in 2024. In this role, he leads Cerus’ U.S. commercial operations. Previously, Mr. Harms served as Vice President, US Sales, West and Senior Director, U.S. Sales and Strategic Accounts after joining Cerus in 2020. Prior to joining Cerus, Mr. Harms held commercial and sales leadership roles at iRhythm Technologies and Sonendo. He also spent more than a decade at AngioDynamics, where he held roles of increasing responsibility, including Regional Business Manager, Corporate Accounts Manager, and Senior Sales Representative. Earlier in his career, Mr. Harms held sales roles at Tyco Healthcare/Covidien and Eli Lilly and Company. Mr. Harms received his B.S. in Marketing and International Business from Iowa State University.

Melody Holtan
Vice President, Product and Portfolio Management

Ms.  Holtan serves as Vice President, Product & Portfolio Management at Cerus Corporation. Since joining Cerus in 2007, she has held roles of increasing responsibility across commercialization operations, product management, blood center services, and portfolio management. During her tenure at Cerus, Ms. Holtan has contributed to key company milestones including the opening of Cerus’ European headquarters, and FDA approvals and US launches of INTERCEPT platelets, INTERCEPT plasma, and INTERCEPT Fibrinogen Complex. Prior to joining Cerus, Ms. Holtan began her career in project management including roles at Novak Construction and at Integrated Project Management in Chicago, Illinois, where she worked with clients across the medical device and healthcare sectors. She received her B.S. in Chemical Engineering from the University of New Hampshire.

Chrystal Jensen
Chief Legal Officer and General Counsel

Ms. Jensen was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Jensen served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Jensen received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.

Mark Jones
Vice President, Technical Operations

Mr. Jones was appointed Vice President, Technical Operations in June 2024 to oversee Device Hardware & Software Engineering, Disposables Development, Chemical Manufacturing Controls, and Quality Assurance. Previously, he served as Vice President, Device Development Disposables & Platelet & Plasma Biology. Prior to joining Cerus in 2020, Mr. Jones served as Vice President, R&D at Adherium Ltd., a digital health start-up company focused on promoting medication adherence. He also previously served as Vice President, Design & Engineering, Flex Ltd., a global original design manufacturer (ODM) providing design, engineering, manufacturing, & supply chain services. Additionally, through previous leadership roles with Fenwal and Baxter, Mr. Jones brings over 15 years of transfusion medicine industry experience to Cerus. Mr. Jones holds B.S. and M.S. degrees in plastics engineering from the University of Massachusetts Lowell.

Nina Mufti, Ph.D.
Senior Vice President, Research and Development

Dr. Mufti was promoted to Senior Vice President, Research and Development in June 2024. In her role, she oversees research and development activities for all Cerus programs. Prior to her promotion, she held the role of Vice President, Development and Red Blood Cell (RBC) Program Leader. Since joining Cerus in 2007, Dr. Mufti has guided the product design and development efforts for the INTERCEPT RBC System and served as Vice President, Development since 2012, overseeing Cerus’ PMA submissions and approvals for INTERCEPT platelets and plasma. Prior to Cerus, Dr. Mufti worked at Nektar Therapeutics on the development, registration and commercialization of drug and device combination products. Dr. Mufti completed her Ph.D. in Biochemical Engineering at Cornell University, and her Bachelor of Science, Biochemistry and Bachelor of Applied Science, Chemical Engineering at the University of Ottawa.

Bianca Vos
Vice President, Administration

Ms. Vos has been with Cerus Europe B.V. since 2007 and currently serves as Vice President of Administration. Over the course of her tenure, she has held a series of leadership roles with increasing responsibility across human resources, administration, and operations.  As Vice President of Administration, Ms. Vos oversees the company’s international HR and administrative functions outside the United States. She is responsible for driving operational excellence, ensuring compliance with local employment regulations, supporting organizational development, and leading initiatives that strengthen the company’s people, processes, and workplace operations.